We are delighted to announce that our upcoming project, CCHFVACIM, has received funding from the Commission as part of the Horizon Europe programme ! Following the success of CCHFVaccine, this new endeavor marks a significant step forward in our mission to combat Crimean Congo Hemorrhagic fever (CCHF) by developing an mRNA vaccine.
With 11 partners onboard, including coordination by ERINHA, CCHFVACIM represents a collaborative effort to urgently address the threat posed by this dangerous pathogen. The project, spanning over 4 years and with a budget of 8 million euros, aims to accelerate the development of effective countermeasures against CCHF.
The kick-off meeting for CCHFVACIM was held in Paris on 19-20 March 2024, marking the commencement of this ambitious venture. As we prepare to delve into this follow-up project, our team remains steadfast in our commitment to advancing scientific knowledge and translating it into tangible solutions for the prevention and treatment of CCHF.
Stay tuned for further updates as we embark on this exciting journey towards safeguarding public health !